Activist shareholder seeking to replace drug company’s board
Depomed Inc. DEPO -2.92 % said it would hold a special shareholder meeting on Nov. 15 as the drug company battles Starboard Value LP’s efforts to replace its board.
20:37 Brazil grants antitrust approval for FMC Technologies, Technip merger12
23:15 Howard Schultz stepping down as Starbucks CEO; current COO to replace him12
21:05 Starbucks Chief Howard Schultz to Step Down Next Year11
15:54 Johnson & Johnson raising takeover offer for Actelionl: source14